|
|
|
| Tuesday, May 22, 2012 |
|
|
|
4:00 p.m. |
|
Pharmacology Seminars
Chemical Biology of Methyl-Lysine
The 2012 Nina W. Werblow Lecture
4:00 p.m.: Stephen V. Frye, Ph.D., professor, division of medicinal chemistry and natural products, and director, Center for Integrative Chemical Biology and Drug Discovery, Eshelman School of Pharmacology, University of North Carolina, Chapel Hill
|
4:00 p.m. |
|
Center for Studies in Physics and Biology Seminars
Statistical Mechanics of the Genetic Code: A Glimpse of Early Life?
Nigel Goldenfeld, Ph.D., professor of physics, University of Illinois, Urbana-Champaign
|
|
| Wednesday, May 23, 2012 |
|
|
|
11:00 a.m. |
|
Other Tri-Institutional Events
Role of Next-generation Synthesis in Small Molecule Probe and Drug Discovery
Michael Foley, Ph.D., director, chemical biology platform, Broad Institute of Harvard and MIT
|
4:30 p.m. |
|
Other Seminars
So You Want to Start a Biotech Company, Hmmm…?
RU Biotech Forum Seminar Series on Entrepreneurship
Ron Cohen, M.D., president and CEO, Acorda Therapeutics
|
|
| Thursday, May 24, 2012 |
|
|
|
10:30 a.m. |
|
Other Tri-Institutional Events
Signaling by WW Domain in Golabi Syndrome and Hippo Tumor Suppressor Pathway
Marius Sudol, Ph.D., staff scientist, Geisinger Clinic
|
11:00 a.m. |
|
Chemical Biology Seminar Series
Dicer and Beyond: Regulatory RNAs in Humans and Bacteria
11:00 a.m.: Jennifer Doudna, Ph.D., professor of biochemistry, biophysics and structural biology, University of California, Berkeley; investigator, Howard Hughes Medical Institute
|
11:00 a.m. |
|
Other Tri-Institutional Events
Harnessing the Complexities of Life with Synthetic Chemistry
Dirk Trauner, Ph.D., professor of chemical biology, University of Munich
|
2:00 p.m. |
|
Other Tri-Institutional Events
Molecular Mechanisms of Synapse Formation and Synaptic Specificity
2:00 p.m.: Peter Scheiffele, Ph.D., professor, University of Basel
|